Companies
Jack in the Box Adds Starbucks CFO to Board as Board Refreshes
Rachel Ruggeri, former Starbucks CFO, joins Jack in the Box’s board amid leadership transition and board refreshment efforts.
Einride partners with Nvidia for autonomous trucking tech
Einride has announced a partnership with Nvidia centred on autonomous trucking technology, according to company news coverage.
Avantor Appoints Todd Garner as Chief Financial Officer
Avantor names former CONMED CFO Todd Garner as its new executive vice president and chief financial officer, replacing interim CFO Steve Eck.
KazMunayGas completes $500m tender offer for 2030 notes
KazMunayGas National Company completed a $500 million tender offer for its 5.375% notes due 2030, accepting the full amount at the early tender deadline of September 3.
Sinclair Boosts 2025–26 Political Ad Budget to Over $375 Million Amid Regulatory Tailwinds
Sinclair Inc. raised its political advertising spending target for the 2025–26 cycle to at least $375 million, reflecting a broader U.S. trend toward elevated campaign expenditures and regulatory clarity.
Lonza outlines CDMO growth plan and cash focus at Morgan Stanley conference
CFO Philippe Deecke said Lonza aims for 10%‑13% organic growth, caps CapEx at mid‑teens of sales and targets 32%‑34% margins for specialized modalities.
AI-linked stocks fall as tech bosses call for slowdown
Shares in AI companies and related sectors drop after executives warn of 'reckless' development and potential risks, while some investors argue for continued investment.
EU Eyes Canada as First Potential Associate Member
European Commission President Ursula von der Leyen proposes expanding ties with Canada to an associate membership status, marking a potential shift in EU-Canada relations.
Baltic Classifieds Group appoints Sean Glithero as independent director
Sean Glithero, a qualified Chartered Accountant with extensive finance experience, joins the board of Baltic Classifieds Group PLC as an independent non-executive director, set to chair the Audit Committee from January 2027.
SWISSto12 Partners with Mitsubishi Electric on Satellite Tech
Swiss satellite maker SWISSto12 signed an MoU with Mitsubishi Electric to pursue joint opportunities in Japan and Asia Pacific, while also landing a contract for phased array antennas for Japan's secure communications program.
FDA Accepts Takeda’s zasocitinib Application for Plaque Psoriasis
Takeda’s oral TK2 inhibitor for moderate-to-severe plaque psoriasis enters FDA review, with a target action date set for Q1 2027 under PDUFA.
Palomar Sees Growth Broaden Across Lines as Earnings Streak Hits 15
Palomar Holdings reported 27% first-half earnings growth and raised guidance for a third time in 2026, citing expanding crop, surety and reinsurance businesses at the KBW Insurance Conference.
Charter Raises Cox Synergy Target to Over $1 Billion, Trims Leverage Goal
CFO Jessica Fischer said Charter’s combined footprint will exceed 70 million passings post-integration, with nearly half the Cox synergies expected quickly.
C2N Diagnostics partners with Cambridge Cognition to deliver integrated Alzheimer’s diagnostics in the UK
The collaboration combines C2N's PrecivityAD2 blood test with Cambridge Cognition's CANTAB Pathway cognitive assessment, using The Alzheimer’s Trust's phlebotomy and MRI network to address the UK's dementia diagnosis gap.
German Auto Workers Mobilize for Nationwide Union Protests
IG Metall calls for more than 280 actions across Germany as automakers face overcapacity, job cuts and rising Chinese competition.
mAbxience and Sandoz Team Up on Emicizumab Biosimilar
Fresenius-owned mAbxience and Sandoz signed a licensing, development, manufacturing and commercialization agreement for an emicizumab biosimilar referencing Hemlibra, with an estimated global reference market of around $5.7 billion.
Jazz Pharmaceuticals Raises ZYHERA Sales Guidance Amid Rare-Disease Expansion
Revenue hits $1.2 billion in Q2 2026 as Jazz Pharmaceuticals accelerates pipeline growth, citing strong performance across key brands and strategic acquisitions.
iA Financial Group targets 17%+ ROE and growth at Scotiabank summit
CEO Denis Ricard said iA Financial aims for a 17%‑plus return on equity, modest buybacks and expansion of its U.S. insurance business while investing heavily in AI tools.
Iovance Raises Outlook on AMTAGVI Sales Momentum at Wells Fargo Conference
Cash-rich biotech sees Q2 AMTAGVI sales surge 52%, gross margins jump; guides to ~70% long-term gross margin with runway into late 2028.
Zurich Appoints Alex Wells as Head of US Operations
Zurich Insurance names internal candidate Alex Wells to lead its US business, replacing Sierra Signorelli who departs after nine years with the firm.
Protagonist Therapeutics reports $850M cash, $300M buyback, launches oral IL-23 drug
The biotech firm ended Q2 with $850 million in cash, announced a $300 million share repurchase and introduced icotrokinra, an oral IL‑23 blocker for inflammatory diseases.
EyePoint Shares Fall on Missed Primary Endpoint in Wet AMD Trial
EyePoint Pharmaceuticals reported its DURAVYU implant missed non-inferiority versus Eylea in the LUGANO trial, though treatment-burden benefits were strong as the company looks ahead to the LUCIA readout.
Harmony Biosciences projects >$1 bn WAKIX revenue, outlines pipeline and BD targets
CEO Jeff Dayno said WAKIX is on track for over $1 billion in 2024 revenue, while the company targets new product launches and acquisitions through 2032.
Freeport-McMoRan outlines copper growth strategy at Jefferies conference
CEO Kathleen Quirk detailed plans to ramp up Indonesia and U.S. output, launch a leaching program and expand the Bagdad project, targeting a 60% rise in U.S. copper production by 2030.